Holen Sie sich die Stockscreener-App
0.60
0.00%
0.00
Handel nachbörslich:
.60
Schlusskurs vom Vortag:
$0.60
Offen:
$0.59
24-Stunden-Volumen:
85,036
Relative Volume:
0.65
Marktkapitalisierung:
$55.26M
Einnahmen:
$775.30K
Nettoeinkommen (Verlust:
$-35.32M
KGV:
-1.0714
EPS:
-0.56
Netto-Cashflow:
$-19.15M
1W Leistung:
+0.81%
1M Leistung:
-32.05%
6M Leistung:
-32.65%
1J Leistung:
-25.84%
1-Tages-Spanne:
$0.5863
$0.65
1-Wochen-Bereich:
$0.55
$0.65
52-Wochen-Spanne:
$0.4301
$1.23
VolitionRX Ltd Stock (VNRX) Company Profile
Firmenname
VolitionRX Ltd
Sektor
Branche
Telefon
646 650 1351
Adresse
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-01 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-02-17 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-03-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-16 | Eingeleitet | Maxim Group | Buy |
| 2018-05-14 | Bestätigt | The Benchmark Company | Buy |
| 2016-09-07 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-02-01 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
VolitionRX Ltd Aktie (VNRX) Neueste Nachrichten
VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - Defense World
VolitionRx (NYSE:VNRX) Now Covered by Analysts at StockNews.com - Defense World
Volition to share new 'NETs in sepsis management' data insights at upcoming webinar - Quantisnow
VolitionRx adds Dr. Ethel Rubin to its board By Investing.com - Investing.com South Africa
VolitionRx adds Dr. Ethel Rubin to its board - Investing.com India
Volition Appoints Dr. Ethel Rubin as an Independent Director - Quantisnow
VolitionRx announces executive employment updates - Investing.com India
Agency News | ⚡Tamil Nadu’s Veterinary Varsity Directed by High Court To Consider Transgender Student’s Application - LatestLY
Madras HC directs TN veterinary varsity to not reject transgender's application over identity - Hindustan Times
Madras High Court Orders TN Veterinary University to Accept Transgender Candidate's Application - Law Trend
Don't reject transgender's application over identity HC tells TN veterinary varsity - The Week
Madras High Court Upholds Transgender Rights for Veterinary Course Admissions - Devdiscourse
Volato Facing Class-action WARN Act Lawsuit - Aviation International News
VolitionRx offers oncology assets for licensing - Investing.com India
VolitionRx offers oncology assets for licensing By Investing.com - Investing.com Australia
Volition Announces Board of Directors - TechBuzz News
CRYPTOPSY's New Shirts Are Very Serious - Metal Injection
Terminated Volato Employees File Class Action Lawsuit - FLYING
LifeLabs workers in GTA poised to strike if deal not reached by Saturday - CP24
Investing in VolitionRX Ltd (VNRX): What You Must Know - Knox Daily
Volition Hosts KOL Roundtable on Sepsis - Yahoo Finance
VolitionRX Ltd [VNRX] Records 200-Day SMA of $0.7821 - Knox Daily
The Potential Rise in the Price of VolitionRX Ltd (VNRX) following insiders activity - Knox Daily
VNRX: Nu.Q Vet Test is now available in 17 countries. Cost cutting continues in a plan to be cash flow neutral in 2025. Management focused on signing licensing deals for Capture-PCR (human cancer detection method) and Nu.Q NET for sepsis. $7.0 million fi - Yahoo Finance
Understanding the Risks of Investing in VolitionRX Ltd (VNRX) - Knox Daily
Comparing OncoCyte (NASDAQ:OCX) & VolitionRx (NYSE:VNRX) - Defense World
VolitionRx (NYSEAMERICAN:VNRX) Stock Price Passes Above 50-Day Moving Average of $0.00 - Defense World
VolitionRx Limited (NYSE:VNRX) Director Guy Archibald Innes Purchases 150,000 Shares - Defense World
VolitionRX Ltd (VNRX) Q2 2024 Earnings Call Transcript Highlight - GuruFocus.com
Benchmark Reiterates Hold Rating for VolitionRx (NYSE:VNRX) - Defense World
VolitionRx Limited (AMEX:VNRX) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: VolitionRx reports strong growth and optimistic outlook - Investing.com
VolitionRX: Q2 Earnings Snapshot - San Antonio Express-News
Market Highlights: VolitionRX Ltd (VNRX) Ends on a Low Note at 0.53 - The Dwinnex
Form 424B5 VOLITIONRX LTD - StreetInsider.com
SEC Form 424B5 filed by VolitionRX Limited - Quantisnow
VolitionRx announces $7 million stock and warrant sale - Investing.com India
VolitionRx (NYSEAMERICAN:VNRX) Share Price Passes Above 50 Day Moving Average of $0.00 - Defense World
VNRX Stock Touches 52-Week Low at $0.55 Amid Market Challenges - Investing.com
VolitionRx (NYSEAMERICAN:VNRX) Shares Pass Above Fifty Day Moving Average of $0.00 - Defense World
Q1 2025 Adani Energy Solutions Ltd Earnings Call Transcript - Stockxpo
VolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.com - Defense World
Head And Neck Cancer Diagnostics Market Growth Analysis With Investment Opportunities - EIN News
Virax Biolabs Group (NASDAQ:VRAX) & VolitionRx (NYSE:VNRX) Head-To-Head Review - Defense World
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing - StockTitan
Envela Corp shareholders elect board, ratify auditor By Investing.com - Investing.com India
VolitionRx expands stock plan and authorized shares By Investing.com - Investing.com India
StockNews.com Initiates Coverage on VolitionRx (NYSE:VNRX) - Defense World
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts - Quantisnow
VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting - StockTitan
Volition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporation - Quantisnow
Finanzdaten der VolitionRX Ltd-Aktie (VNRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.48%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):